RHS Continues Global Launch Of IVF Product (Bioshares)

Jun 05, 2015 -

Reproductive Health Science (RHS)  made a backdoor listing on the ASX last year at 20 cents a share. The company markets EmbryoCellect™, a product which allows correct chromosome composition to be assessed in embryos from a single cell.

Read full article

< Back to all news